Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × penpulimab × Clear all

NCT05485350 2022-08-03

Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05319886 2022-05-20

AP

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms